VolitionRx Limited Form 8-K Filing

VolitionRx Limited filed a Form 8-K on July 17, 2026, to report an amendment to its Certificate of Incorporation. The amendment, effective upon filing with the Secretary of State of Delaware, reduces the number of authorized shares of common stock from 325,000,000 to 150,000,000. This change was previously approved by the board of directors on May 11, 2026, and subsequently by the stockholders at the 2026 annual meeting held on July 17, 2026. The annual meeting also included votes on the election of seven directors, ratification of the independent auditor, advisory approval of executive compensation, and approval of the 2026 Stock Incentive Plan. The company had 8,627,191 shares of common stock outstanding as of May 26, 2026, with 4,261,161 shares represented at the meeting. The voting results for all proposals are detailed in the filing.